医学
内科学
肿瘤科
肺癌
皮疹
荟萃分析
不利影响
免疫疗法
无进展生存期
无容量
临床终点
癌症
临床试验
总体生存率
作者
Heng Lin,Chenhui Ma,Aihong Zhong,Huanping Zang,Wenxin Chen,Lixiu Li,Yuyin Le,Qiang Xie
标识
DOI：10.2174/1386207326666230808112656
摘要
Anti-angiogenesis combined with immunotherapy demonstrated satisfactory antitumor activity and an acceptable toxicity profile in patients with advanced NSCLC. The pooled results of our meta-analysis provided further evidence supporting the favorable efficacy and safety of this therapeutic strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Nole
Copyright
OK
kimyb
愉快的真
halooo
Criminology34
GingerF
22336
尊嘟假嘟
张荣基
arniu2008
颂歌998
ting
半夏
Oracle
skearthy
morena
含糊的幻波
皖公网安备34019202002308
